Within the medical research community, there is concern the immunity either acquired or acquired through vaccine will be short-lived. There needs to be a detailed record of the vaccinated and their experience after their vaccine. There can be a great deal of hope in that record, but, it could be a window of limitations as well.
The F.D.A. (click here) is expected to issue an emergency authorization of Pfizer’s vaccine on Saturday. Sanofi and GlaxoSmithKline said their experimental vaccine did not appear to work well in older adults, a significant setback....
...What happens next?
Since the panel’s vote on Thursday was only advisory, the vaccine must now secure the authorization of the federal Food and Drug Administration. That’s ordinarily a long and laborious process.
But that is highly unlikely to be the case this time. Barring last-minute snags, the F.D.A. is expected to issue an emergency authorization on Saturday.
And that means the first Covid-19 vaccinations to be administered in the U.S. outside the confines of an experiment are likely to begin early next week. First in line to get it are health care workers and nursing home residents....
